First Trust Advisors LP Has $1.96 Million Stock Position in Relx Plc (NYSE:RELX)

First Trust Advisors LP lifted its position in shares of Relx Plc (NYSE:RELX - Free Report) by 799.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,129 shares of the technology company's stock after purchasing an additional 38,335 shares during the quarter. First Trust Advisors LP's holdings in Relx were worth $1,959,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. CENTRAL TRUST Co increased its holdings in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after buying an additional 529 shares during the period. Versant Capital Management Inc bought a new stake in Relx in the fourth quarter valued at about $31,000. Sierra Ocean LLC bought a new stake in Relx in the fourth quarter valued at about $43,000. Brown Brothers Harriman & Co. raised its position in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA lifted its stake in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after purchasing an additional 199 shares during the period. 15.02% of the stock is currently owned by institutional investors.

Relx Stock Performance

Relx stock opened at $55.05 on Tuesday. Relx Plc has a 12-month low of $41.94 and a 12-month high of $55.21. The stock has a 50-day simple moving average of $50.10 and a 200 day simple moving average of $48.51. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The stock has a market capitalization of $101.88 billion, a price-to-earnings ratio of 29.59, a P/E/G ratio of 2.73 and a beta of 0.86.

Relx Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is a boost from Relx's previous semi-annual dividend of $0.23. This represents a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is 59.68%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on RELX shares. The Goldman Sachs Group began coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating for the company. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. StockNews.com downgraded shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, Redburn Atlantic initiated coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a "buy" rating on the stock. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.